Association studies of novel obesity-related gene variants with quantitative metabolic phenotypes in a population-based sample of 6,039 Danish individuals.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 21953277)

Published in Diabetologia on September 28, 2011

Authors

K S Burgdorf1, A P Gjesing, N Grarup, J M Justesen, C H Sandholt, D R Witte, T Jørgensen, S Madsbad, T Hansen, O Pedersen

Author Affiliations

1: The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health Sciences, University of Copenhagen, Universitetsparken 1, DIKU Building, Room 1.1.N121, DK-2100 Copenhagen, Denmark. Kristoffer.Burgdorf@sund.ku.dk

Associated clinical trials:

Lifestyle Intervention in a General Population for Prevention of Ischaemic Heart Disease | NCT00289237

Articles by these authors

Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis. Science (2003) 8.79

Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3) Nature (1996) 5.32

Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet (1999) 4.81

Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus. Diabetologia (2001) 3.76

Organochlorine exposure and risk of breast cancer. Lancet (1998) 3.18

Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med (1993) 3.10

Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J Clin Endocrinol Metab (2001) 3.09

The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes. Diabetologia (2007) 3.07

Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes (2001) 3.06

Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia (2011) 2.43

Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. J Clin Endocrinol Metab (2003) 2.41

Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol Psychiatry (2009) 2.29

The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men. Diabetologia (2009) 2.25

A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis. Neurology (2006) 2.24

Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study. Diabetologia (2007) 2.16

Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. J Intern Med (2010) 2.07

'Alarm symptoms' in patients with dyspepsia: a three-year prospective study from general practice. Scand J Gastroenterol (2002) 2.06

Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus. Diabet Med (2008) 2.04

[New discoveries about the cause of diabetes. Type 2 diabetes mellitus changed to "obesity-dependent diabetes mellitus"]. Ugeskr Laeger (2001) 2.02

Strand displacement amplification and homogeneous real-time detection incorporated in a second-generation DNA probe system, BDProbeTecET. Clin Chem (1999) 2.01

The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia (2002) 1.99

The multifunctional roles of the four-and-a-half-LIM only protein FHL2. Cell Mol Life Sci (2006) 1.99

Incidence and remission rates of lower urinary tract symptoms at one year in women aged 40-60: longitudinal study. BMJ (2000) 1.94

Increasing prevalence of specific IgE to aeroallergens in an adult population: two cross-sectional surveys 8 years apart: the Copenhagen Allergy Study. J Allergy Clin Immunol (2000) 1.93

The link between allergic rhinitis and allergic asthma: a prospective population-based study. The Copenhagen Allergy Study. Allergy (2002) 1.90

Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients. Diabetologia (2002) 1.86

Low birthweight is associated with specific changes in muscle insulin-signalling protein expression. Diabetologia (2005) 1.85

Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone (2004) 1.85

Proposal for a histopathological consensus classification of the periprosthetic interface membrane. J Clin Pathol (2006) 1.75

Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes. Diabetologia (2008) 1.75

Smoking as a risk factor for wound healing and infection in breast cancer surgery. Eur J Surg Oncol (2002) 1.72

ANTI-HSP60 and ANTI-HSP70 antibody levels and micro/ macrovascular complications in type 1 diabetes: the EURODIAB Study. J Intern Med (2009) 1.68

Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet (1993) 1.68

Smoking and alcohol abuse are major risk factors for anastomotic leakage in colorectal surgery. Br J Surg (1999) 1.68

Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine. J Clin Invest (1991) 1.67

Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance. Am J Physiol Endocrinol Metab (2012) 1.63

The prevalence and bothersomeness of lower urinary tract symptoms in women 40-60 years of age. Acta Obstet Gynecol Scand (2000) 1.63

Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients. Diabetes Care (1999) 1.62

Cancer occurrence in Danish diabetic patients: duration and insulin effects. Diabetologia (2011) 1.62

Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection. Diabetologia (2005) 1.60

Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1. Lancet (1995) 1.58

Plasma N-terminal pro-brain natriuretic peptide as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria. Diabetologia (2004) 1.56

Puncture technique and postural postdural puncture headache. A randomised, double-blind study comparing transverse and parallel puncture. Acta Anaesthesiol Scand (1998) 1.56

Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia (2012) 1.55

Expression of the major insulin regulatable glucose transporter (GLUT4) in skeletal muscle of noninsulin-dependent diabetic patients and healthy subjects before and after insulin infusion. J Clin Endocrinol Metab (1993) 1.55

The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients--the EUGENE2 study. Diabetologia (2008) 1.53

Partial and whole gene deletion mutations of the GCK and HNF1A genes in maturity-onset diabetes of the young. Diabetologia (2007) 1.52

Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass. Diabetologia (2012) 1.52

Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people. Clin Exp Immunol (2003) 1.50

A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies. J Clin Invest (1996) 1.50

Evaluation of a semi-quantitative food frequency questionnaire to estimate iodine intake. Eur J Clin Nutr (2001) 1.50

Incidence of gallstones in a Danish population. Gastroenterology (1991) 1.49

Patient specific biomodel of the whole aorta - the importance of calcified plaque removal. Vasa (2011) 1.48

Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes. Diabet Med (2008) 1.47

Socioeconomic status and trends in risk factors for cardiovascular diseases in the Danish MONICA population, 1982-1992. J Epidemiol Community Health (2000) 1.46

Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults. Gut (2003) 1.46

Gonorrheal conjunctivitis an old disease returned. JAMA (1966) 1.46

Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. J Clin Invest (1996) 1.45

Determinants of vitamin D status in a general population of Danish adults. Bone (2011) 1.45

The FOXC2 -512C>T variant is associated with hypertriglyceridaemia and increased serum C-peptide in Danish Caucasian glucose-tolerant subjects. Diabetologia (2003) 1.43

Survival of rectal cancer patients in Denmark during 1994-99. Colorectal Dis (2004) 1.42

Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Obes Surg (2012) 1.42

Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes. Diabetes (1978) 1.41

Expanding the range of ZNF804A variants conferring risk of psychosis. Mol Psychiatry (2010) 1.41

Breast cancer and dieldrin. Lancet (2000) 1.40

[What do hospital staff's smoking habits mean for knowledge, attitude and counseling practice related to smoking?]. Ugeskr Laeger (2001) 1.40

Effect of endurance training on glucose transport capacity and glucose transporter expression in rat skeletal muscle. Am J Physiol (1990) 1.40

Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. Proc Natl Acad Sci U S A (1995) 1.40

Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus. Acta Med Scand (1981) 1.40

Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and Type II diabetes. Diabetologia (2001) 1.39

[Patient information prior to sterilization]. Ugeskr Laeger (1992) 1.39

Fluctuation in dyspepsia subgroups over time. A three-year follow-up of patients consulting general practice for dyspepsia. Dig Liver Dis (2002) 1.39

[Treatment of patients with gallstones. An evaluation of medical technology]. Ugeskr Laeger (1999) 1.38

[Treatment of primary breast cancer. Consequences of mammographic screening in the municipality of Copenhagen]. Ugeskr Laeger (1996) 1.38

Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action. Diabetologia (2008) 1.35

Impact on weight dynamics and general growth of the common FTO rs9939609: a longitudinal Danish cohort study. Int J Obes (Lond) (2008) 1.34

The epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors. J Intern Med (1994) 1.34

A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes. Diabetologia (2011) 1.31